Evofem Biosciences, Inc.
Index- P/E- EPS (ttm)-18.97 Insider Own2.30% Shs Outstand163.14M Perf Week233.23%
Market Cap13.51M Forward P/E- EPS next Y-1.16 Insider Trans94.32% Shs Float155.32M Perf Month208.36%
Income-192.10M PEG- EPS next Q-1.35 Inst Own13.50% Short Float1.28% Perf Quarter-80.38%
Sales11.40M P/S1.19 EPS this Y25.70% Inst Trans-13.10% Short Ratio0.12 Perf Half Y-83.33%
Book/sh-11.55 P/B- EPS next Y46.40% ROA-303.30% Target Price22.10 Perf Year-94.10%
Cash/sh- P/C- EPS next 5Y- ROE272.20% 52W Range0.28 - 18.60 Perf YTD-81.00%
Dividend- P/FCF- EPS past 5Y22.60% ROI- 52W High-94.25% Beta0.11
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin59.50% 52W Low289.09% ATR0.15
Employees119 Current Ratio0.10 Sales Q/Q290.90% Oper. Margin- RSI (14)65.86 Volatility42.52% 18.02%
OptionableYes Debt/Eq- EPS Q/Q65.90% Profit Margin- Rel Volume28.97 Prev Close1.07
ShortableYes LT Debt/Eq- EarningsMay 04 AMC Payout- Avg Volume17.20M Price1.07
Recom2.20 SMA20184.68% SMA50-15.11% SMA200-82.30% Volume343,590,688 Change0.00%
Oct-14-21Downgrade Morgan Stanley Equal-Weight → Underweight $0.80
Oct-02-20Initiated Stifel Buy $5
Aug-20-20Initiated Morgan Stanley Equal-Weight $3
Jun-08-20Initiated Piper Sandler Overweight $11
Oct-16-19Resumed Cantor Fitzgerald Overweight $9
Jun-28-22 05:31PM  
Jun-27-22 02:13PM  
Jun-24-22 12:10PM  
Jun-16-22 08:46AM  
Jun-07-22 08:15AM  
Jun-02-22 08:46AM  
May-20-22 09:13AM  
May-19-22 05:59PM  
May-10-22 08:46AM  
May-06-22 08:46AM  
May-05-22 09:00AM  
May-04-22 04:01PM  
Apr-27-22 08:46AM  
Apr-26-22 08:46AM  
Apr-25-22 09:00AM  
Apr-19-22 06:52AM  
Apr-11-22 06:48AM  
Apr-07-22 06:50AM  
Mar-31-22 01:00PM  
Mar-04-22 06:48AM  
Mar-03-22 04:00PM  
Mar-01-22 10:22AM  
Feb-17-22 09:00AM  
Feb-09-22 09:00AM  
Feb-08-22 09:00AM  
Jan-21-22 05:38PM  
Jan-19-22 09:00AM  
Jan-12-22 10:18AM  
Jan-04-22 07:00AM  
Dec-21-21 12:15AM  
Dec-16-21 07:00AM  
Dec-09-21 08:00AM  
Dec-08-21 06:30AM  
Nov-30-21 08:00AM  
Nov-22-21 06:50AM  
Nov-19-21 07:00AM  
Nov-15-21 04:00PM  
Nov-10-21 07:00AM  
Nov-04-21 08:00AM  
Oct-28-21 08:00AM  
Oct-20-21 08:00AM  
Oct-12-21 06:31AM  
Oct-08-21 08:00AM  
Sep-30-21 08:00AM  
Sep-27-21 08:00AM  
Sep-16-21 08:00AM  
Sep-09-21 08:00AM  
Sep-02-21 09:03AM  
Sep-01-21 08:00AM  
Aug-31-21 12:00PM  
Aug-11-21 04:27PM  
Jul-28-21 08:00AM  
Jul-14-21 08:00AM  
Jun-01-21 09:00AM  
May-25-21 08:00AM  
May-21-21 06:50AM  
May-18-21 09:06AM  
May-17-21 11:02PM  
May-12-21 04:19PM  
May-06-21 04:01PM  
Apr-28-21 11:00AM  
Apr-22-21 08:00AM  
Apr-21-21 08:00AM  
Mar-29-21 04:05PM  
Mar-25-21 07:58AM  
Mar-24-21 10:00PM  
Mar-17-21 08:00AM  
Mar-16-21 08:00AM  
Mar-06-21 03:05AM  
Mar-05-21 01:00PM  
Mar-04-21 04:00PM  
Feb-23-21 08:00AM  
Feb-18-21 08:00AM  
Feb-16-21 08:00AM  
Feb-04-21 09:00AM  
Jan-12-21 09:05AM  
Dec-22-20 07:00AM  
Dec-21-20 09:00AM  
Dec-17-20 07:00AM  
Dec-12-20 03:12PM  
Dec-11-20 08:00AM  
Dec-03-20 07:00AM  
Nov-20-20 08:30AM  
Nov-12-20 08:30AM  
Nov-09-20 11:00PM  
Oct-27-20 08:00AM  
Oct-26-20 09:00AM  
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PELLETIER SAUNDRA LChief Executive OfficerMay 27Buy0.35141,00049,702236,722May 31 08:55 AM
File Justin J.Chief Financial OfficerDec 20Buy0.3740,59415,020480,982Dec 20 04:20 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryDec 20Buy0.3925,0009,725336,422Dec 20 04:20 PM
PELLETIER SAUNDRA LChief Executive OfficerDec 20Buy0.38135,00050,625985,837Dec 20 04:19 PM